Aviva appoints Claudia Arney to its Board as Independent Non-Executive Director

– UK, London – Aviva plc (LSE:AV) has appointed Claudia Arney as an independent non-executive director of the Company with effect from 8 February 2016. She will also join the Nomination Committee.

Claudia has a wide range of experience as both an executive and non-executive director across financial services, digital and government and brings a wealth of expertise transforming and expanding businesses online and building digital capabilities. She is currently a non-executive director of Derwent London plc, Halfords Group plc and the Premier League. She is also a member of the Advisory Board of the Shareholder Executive.

Previously Claudia was Deputy Chairman and Senior Independent Director of Telecity plc until January 2016. She was also Chairman of the Public Data Group from 2012 to 2015 and a non-executive director of Which?, Doctors.net.uk, Transport for London and Partnerships UK. In her executive career, Claudia was Group Managing Director of Emap between 2008 and 2010 and was responsible for transforming the predominantly print trade publishing business into a digital data and information business. Prior to that she was Director of the Enterprise and Growth Unit at HM Treasury, and Executive Director at Goldman Sachs.

Sir Adrian Montague, Chairman, said: “Claudia is a very welcome addition to Aviva’s board. Claudia’s experience as both an executive and a non-executive in a variety of sectors, including government and financial services will be invaluable to Aviva. Claudia has a wealth of digital and technological experience and I am confident she will be a real asset to the Board.”

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

here, the original post =>